Introduction
Classical swine fever (CSF) is a highly contagious disease of swine. The etiological agent, classical swine fever virus (CSFV), is a small, enveloped virus with a positive, single-stranded RNA genome and, along with bovine viral diarrhea virus (BVDV) and border disease virus (BDV), is classified as a member of the genus Pestivirus within the family Flaviviridae (Fauquet et al., 2005) . The approximately 12.3-kb CSFV genome contains a single open reading frame that encodes a 3898-amino-acid polyprotein and ultimately yields 11 to 12 final cleavage products (NH 2 -Npro-C-E rns -E1-E2-p7-NS2-NS3-NS4A-NS4B-NS5A-NS5B-COOH) through co-and posttranslational processing of the polyprotein by cellular and viral proteases (Rice, 1996) . Structural components of the CSFV virion include the Core protein and glycoproteins E rns , E1, and E2. The function of glycoproteins, as major virulence determinants in swine, has been studied in detail (Meyers et al., 1999; Risatti et al., 2005a Risatti et al., ,b, 2006 Risatti et al., , 2007 Tews et al., 2009; Van Gennip et al., 2004) . Limited knowledge exists to explain the function of the Core protein in Pestiviruses. CSFV Core protein, as in other Pestiviruses, is a small, highly basic polypeptide (Meyers et al., 1989) . In BVDV, Core protein has been described as lacking significant secondary structure and, being a highly basic protein, capable of binding to RNA, although with low affinity and specificity (Murray et al., 2008) . In CSFV, Core, expressed as recombinant protein, has been associated with the regulation of cellular transcriptional activation (Liu et al., 1998) . A broader knowledge of the biological properties of hepatitis C virus (HCV) Core protein, a close relative of Pestiviruses, is available. HCV Core has been shown to interact with itself for selfassembling in nucleocapsid-like particles in the presence of nucleic acids (Kunkel et al., 2001) ; with HCV proteins NS5A and E1 (Goh et al., 2001; Lo et al., 1996; Masaki et al., 2008) , with HCV RNA (Fan et al., 1999; Shimoike et al., 1999; Tanaka et al., 2000) , and with host cellular proteins (Jin et al., 2000; Mamiya and Worman, 1999; Otsuka et al., 2000; Yoshida et al., 2002; You et al., 1999) . Interaction of Core protein with cellular proteins leads to modulation of signaling pathways, cell transformation and proliferation, regulation of cellular and viral gene expression, apoptosis, and alteration of lipid metabolism that affects HCV pathogenesis (Giannini and Brechot., 2003; Lai and Ware, 2000; Levrero, 2006; McLauchlan, 2000; Ray and Ray, 2001; Tellinghuisen and Rice, 2002) . Interaction of HCV Core protein with cell molecules impairs the host's immune response by mechanisms that result in suppression of IL-12 synthesis in human Virology 407 (2010) 129-136 Contents lists available at ScienceDirect Virology j o u r n a l h o m e p a g e : w w w. e l s e v i e r. c o m / l o c a t e / y v i r o macrophages (Eisen-Vandervelde et al., 2004) , T cell dysfunction (Yao et al., 2007) , and inhibition of T-lymphocyte activation and proliferation (Chen et al., 1994; Kittlesen et al., 2000; Yao et al., 2001) . Discovery of host proteins that interact with CSFV proteins may unravel the biological properties of CSFV Core protein, including the unknown roles in virus virulence and pathogenesis. To increase understanding of the functions of CSFV Core protein, we identified swine proteins that directly interact with Core of CSFV strain Brescia by means of the yeast two-hybrid system using a swine primary macrophage cDNA expression library. Screening revealed that swine proteins specifically bind to Core protein. Of particular interest, two proteins SUMO-1 and UBC9 involved in the cellular SUMOylation pathway (Niedenthal, 2007) , specifically bind to Core protein. SUMOylation is a process that involves covalent attachment of small ubiquitin-like modifier (SUMO) proteins to specific lysine residues in target proteins (Kerscher, 2007; Sarge and Park-Sarge., 2009) . Three SUMO isoforms, SUMO-1, SUMO-2 and SUMO-3, are expressed in cells; in addition, a pseudogene encoding SUMO-4 has also been described (Bohren et al., 2007) . UBC9 is the SUMOconjugating enzyme (Niedenthal, 2007) . Like ubiquitin, attachment of SUMO to proteins involves several enzymatic steps, including cleavage of SUMO by the specific activity of sentrin-specific protease (SENP), to yield a mature-SUMO protein that is attached covalently to the SUMO-activating enzyme dimer (SAE1-SAE2), an E1 protein (Okuma et al., 1999 ). The SUMO protein is then transferred from SAE1-SAE2 to SUMO-conjugating enzyme (UBC9), an E2 protein, which attach SUMO to lysine in the target protein. Typically, SUMOylation occurs in the consensus sequence ψKxD/E/P/G (ψ represents a hydrophobic amino acid) (Desterro et al., 1997; Johnson and Blobel., 1997; Rodriguez et al., 2001; Sampson et al., 2001 ). SUMO E3 proteins are able to increase the efficiency of these reactions by associating with UBC9 and target proteins but are not always required for proteins to be SUMOylated (Geiss-Friedlander and Melchior, 2007; Mukhopadhyay and Dasso, 2007) . Conjugation of SUMO can induce protein activation, affect protein stability, and cause changes in protein intracellular locations (Kerscher, 2007) . SUMOylation also plays a role in the replication of the cell genome and regulation of gene expression (Seeler and Dejean., 2003) . Several viruses, including human cytomegalovirus, Epstein-Barr virus, dengue virus, Moloney murine leukemia virus, and vaccinia virus, induce modifications to the host SUMOylation pathway as a mechanism to evade the host immune response (Chiu et al., 2007; Huh et al., 2008; Palacios et al., 2005; Sadanari et al., 2005; Shirai and Mizuta., 2008; Yueh et al., 2006) .
Mapping of the Core-SUMO binding interface was performed by constructing a panel of Core protein mutants where lysine (K) residues were substituted to alanine (A) residues at the predicted SUMO-1 binding motifs and then tested for interactions by means of the yeast two-hybrid system. Similar mutations were introduced into full-length cDNA clones of highly virulent CSFV strain Brescia. Rescued mutant viruses were used to investigate whether the removal of these sites could affect viral infectivity and virulence in swine. Interestingly, K-to-A substitutions in Core that affect binding to SUMO-1 and UBC9 also showed an effect on induction of attenuation of CSFV in swine.
Results
CSFV structural Core protein binds swine SUMO-1 and UBC9 host proteins A yeast two-hybrid system was used to identify interactions between swine macrophage cellular proteins and CSFV Core protein.
An N-terminal fusion of the GAL4 protein DNA binding domain (BD) with CSFV Core protein was utilized as "bait" to screen a swine primary macrophage cDNA library expressed as N-terminal fusion of the GAL4 activation domain (AD). More than 1 × 10 7 independent yeast colonies were screened from a library representing~3 × 10 6 independent clones. Protein interactions were selected after cotransfecting yeast strain AH109 with BD-Core fusion and cDNA library constructs and selecting colonies for growth in defined media lacking amino acids leucine, tryptophan, histidine, and nucleobase adenine. Plasmids recovered from selected yeast colonies were sequenced, and in-frame ORFs were retested for assessing the specificity of the observed protein interaction with CSFV Core protein.
To address the issue of false positive interactions, human lamin C protein expressed as fusion with BD (BD-Lam) was used as "bait" in AH109 yeast cotransfected with the swine macrophage cDNA expression library. Nonspecific interactors were discarded (data not shown). Several specific protein interactions with CSFV Core protein were observed. Two of these proteins, SUMO-1 and UBC9, were selected for further study as both proteins are involved in the cellular SUMOylation pathway. AD-SUMO-1 and AD-UBC9 fusion proteins specifically interacted with CSFV BD-Core fusion protein, but no protein interactions were observed with BD protein alone (Fig. 1) . Also, no interactions were observed between AD-SUMO-1 and BD-Lam proteins. As expected, AD-UBC9 protein interacted with BD-Lam protein, as previously reported (Zhong et al., 2005) . Mapping areas of CSFV Core protein critical for SUMO-1 recognition
SUMOylation generally occurs at specific lysine (K) residues within target proteins harboring the consensus motif ψKxD/E/P/G (where ψ is a bulky hydrophobic residue). The SUMOplot Analysis Program (www.abgent.com/tools/SUMOplot) predicted putative SUMOylation sites harboring the consensus ΨKxD/E/P/G sequence within CSFV strain Brescia Core protein (Fig. 2) . Five residues within CSFV Core, K179, K180, K220, K221, and K246 (relative to the CSFV polyprotein) were identified as putative SUMOylation sites. Multiple alignment of CSFV Core protein derived from isolates of diverse geographical and temporal origins revealed a high degree of conservancy for those K residues (Fig. 3) . To assess the effects of these residues on Core protein interactions with SUMO-1 and UBC9 proteins, K-to-A substitutions were introduced into CSFV Core gene to yield mutant proteins CoreΔS179, CoreΔS180, CoreΔS220, CoreΔS221, CoreΔS246, CoreΔS179/180, CoreΔS220/221, and CoreΔS179/180/220/221 (Table 1) fused to the BD-GAL4. Proteinprotein interactions using the yeast two-hybrid system showed that K220A substitution (CoreΔS220) alone interferes with the ability of Core to interact with UBC9 (Fig. 4) . However, none of the K-to-A substitutions affected the ability of Core to interact with SUMO-1 (data not shown). Moreover, double substitutions K179A/K180A and K220A/K221A within Core did not affect Core-SUMO-1 protein interactions (Fig. 4) . Thus, to determine if there is a cooperative effect mediating Core-SUMO binding, truncated forms of the protein were assayed in the yeast two-hybrid system for interactions with SUMO-1. Both amino and carboxyl termini halves of Core retained their SUMO-1 binding capabilities (Fig. 4) . However, double substitutions K179A/K180A within the Core truncated carboxyl construct and single substitution K221A within the Core-truncated amino construct lack the ability to interact with SUMO-1 (Fig. 4) . Altogether, mapping data indicate that Core residues K179, K180, and K221 mediate the interaction with SUMO-1, while the interaction between Core and UBC9 seems to be mediated by K220.
Development of CSFV SUMO-1 (CoreΔSv) mutant viruses
K-to-A substitutions of the predicted SUMOylation sites in Core (Table 1) infectious full-length cDNA clone (pBIC) (Risatti et al., 2005a) of the highly virulent CSFV strain Brescia. Rescued mutant viruses, named CoreΔS179/180/220/221v, CoreΔS179/180v, CoreΔS220/221v, CoreΔS179v, CoreΔS180v, CoreΔS220v, CoreΔS221v, and CoreΔS246v, bear a set of single or combined K-to-A substitutions in Core at residues K179, K180, K220, K221, and K246 (Table 1 and Fig. 2 ). Nucleotide sequences of mutant virus genomes were identical to their parental DNA plasmids, confirming the presence of the introduced substitutions and lacking undesirable mutations.
Replication of CoreΔSv mutants in vitro
In vitro growth characteristics of mutant viruses CoreΔS179/180/ 220/221v, CoreΔS179/180v, CoreΔS220/221v, CoreΔS179v, CoreΔS180v, CoreΔS220v, CoreΔS221v, and CoreΔS246v were evaluated relative to parental pBIC-derived virus BICv, in a multistep growth curve (Fig. 5) . Primary swine macrophage cell cultures were infected at a multiplicity of infection (MOI) of 0.01 TCID 50 per cell. Virus was adsorbed for 1 hour (time zero), and samples were collected at 2, 24, 48, and 72 hours postinfection (hpi). All mutant viruses exhibited titers similar to parental BICv except CoreΔS179/180/220/221v, with a virus yield approximately 2.5-3 log 10 TCID 50 /ml lower than BICv (Fig. 5 ). This indicates that although none of the introduced mutations individually affected the virus titer, combined mutations significantly affected virus yield.
Evaluation of the role of CSFV Core SUMOylation sites in CSFV virulence in swine
To examine the effects of deletion of Core SUMOylation sites on CSFV virulence, CoreΔSv mutant viruses CoreΔS179/180v, CoreΔS220/221v, CoreΔS220v, CoreΔS221v, CoreΔS246v and CoreΔS179/180/220/221v were intranasally (IN) inoculated into naïve swine, at doses of 10 5 TCID 50 , and monitored for clinical disease relative to swine inoculated with virulent parental virus. BICv exhibited a characteristic virulent phenotype ( Table 2) : none of the control pigs (n = 6) survived the infection, dying, or being euthanized around 8 dpi. Interestingly, quadruple mutant CoreΔS179/180/220/ 221v was completely attenuated in swine. Animals (n = 4) survived the infection and remained clinically normal throughout the entire observation period (21 days). This virus harbors K-to-A substitutions at residues K179, K180, K220, and K221 indentified as mediators of Core-SUMO-1 (K179, K180, and K221) and Core-UBC9 (K220) interactions. In contrast, all animals (n = 5) inoculated with double mutant CoreΔS179/180 (K179A/K180A) displayed severe signs of CSF with three out of five animals succumbing to the disease, while swine inoculated with double mutant CoreΔS220/221v (n = 7) (K220A, K221A) did not show clinical signs during the observation period (21 days) with the exception of one animal showing a transient rise of body temperature by 8 and 12 dpi. Animals (n = 8) inoculated with single mutant CoreΔS221v (K221A) presented a variable behavior: half of the inoculated animas (n = 4) die with CSFassociated symptoms but a significant delay when compared with those animals infected with parental BICv (16.2 dpi, SD = 1.9, VS 8 dpi, SD = 0.9, respectively). The other four animals inoculated with CoreΔS221v survived the disease presenting either a mild CSF disease (two animals) or were asymptomatic showing only a transitory rise in body temperature around 4 dpi. However, animals (n = 6) inoculated with CoreΔS220v (K220A), a substitution that abolishes the Core-UBC9 protein interaction, displayed a milder and delayed onset of the disease relative to animals inoculated with virulent BICv, succumbing to CSF around 17 dpi (SD = 6.4). Meanwhile, pigs (n = 4) inoculated with single mutant CoreΔS246v (K246A), harboring a mutation that does not affect Core-SUMO-1 or Core-UBC9 protein interactions, displayed a progression of disease indistinguishable from parental BICv infection (Table 2 and Fig. 6 ). Overall, these animal experiments suggest that there appears to be a close correlation between disrupting the protein interaction between Core-SUMO-1 and Core-UBC9 as detected in the yeast two-hybrid system with the induction of CSFV attenuation. The effects of mutations introduced in Core on CSFV in vivo spreading were analyzed in inoculated animals. Virus shedding (as per quantification of virus in tonsil scrapings and nasal swabs) and viremia were quantified at times post-inoculation (Fig. 6) . Virus was not detected in samples obtained from animals inoculated with attenuated mutant virus CoreΔS179/180/220/221v (sensitivity of detection ≥1.8 TCID 50 /ml). Virus shedding was also limited in animals inoculated with CoreΔS220/221v, where three of five animals showed transient and low virus titers in blood, tonsil scrapings, and nasal swabs samples around 14 dpi. Shedding of virus was clearly observed in samples obtained from animals inoculated with CoreΔS220v, although observed titers were lower (1.5 to 2.5 log 10 depending of the time point considered) than those measured in samples obtained from animals inoculated with parental BICv (Fig. 6) . A similar pattern of virus shedding was observed in samples coming from animals inoculated with mutant CoreΔS179/180v (Fig. 6 ). Virus titers from clinical samples from animals inoculated with CoreΔS221v presented heterogeneous values, with the higher values being associated with the presence of CSF-related symptoms. Therefore, animals appearing as clinically normal do not show detectable virus titers. Conversely, animals dying of the disease or surviving but presenting CSF-associated symptoms present virus titers in all clinical samples although with values substantially lower than those of the BICv-infected animals. Virulent mutant CoreΔS246v showed a pattern of virus shedding indistinguishable from parental BICv (Fig. 6 ). As with virus attenuation, shedding of CSFV as well as generalization of infection is affected by mutations in the Core protein that have an effect on Core protein interaction with SUMO-1 or UBC9.
Animals that survive inoculation with CoreΔS179/180/220/221v and CoreΔS220/221v were challenged with virulent BICv by 28 dpi were not protected, succumbing to the infection as naïve pigs (data not shown). CSFV-specific antibodies were not detected in sera of animals infected with either CoreΔS179/180/220/221v or CoreΔS220/221v at the time of challenge.
Discussion
Here, we have observed that the structural Core protein of CSFV specifically interacts with SUMOylation pathway proteins SUMO-1 and UBC9. SUMO-1 binds to target proteins as part of posttranslational modifications while UBC9, a protein with a strong sequence similarity to ubiquitin carrier proteins (E2s), catalyzes conjugation of SUMO-1 to a variety of target proteins (Desterro et al., 1997; Gong et al., 1997; Johnson and Blobel., 1997) . SUMO proteins attach covalently to and detach from target proteins to modify their functions (Kerscher, 2007) . Several studies indicate that viral infections affect the cellular SUMOylation pathway (Chang et al., 2009; Chiocca, 2007) . In this work, the specific residues within CSFV Core protein mediating the interaction with SUMO-1 and UBC9 proteins were identified. Disruption of CSFV Core protein interaction yielded recombinant viruses with attenuated phenotypes and limited spreading within infected swine. These data suggest a novel role for Core protein in CSFV pathogenesis and virulence that is associated with the ability of Core protein to interact with host proteins in the cellular SUMOylation pathway.
Modifications of SUMO-1 and UBC9 binding sites in Core yielded a virus (CoreΔS179/180/220/221v) with substantially altered growth characteristics in primary swine macrophage cultures (Fig. 5) . These quadruple K-to-A substitutions might affect virus growth by compromising other uncharacterized functions of CSFV Core, such as roles in virus replication or virion assembly. As might be expected, CoreΔS179/180/220/221v growth defects correlated with attenuation in infected pigs. Although the attenuated CoreΔS viruses did not show a severe growth defect in vitro, they had severe replication impairments during infection in animals. Thus, attenuation and spread of these viruses in vivo might be a function of altered growth in cells, other than macrophages, that normally support growth of wild-type CSFV. Other viral infections have been shown to affect the cellular SUMOylation pathway. Ebola virus Zaire VP35, adenovirus CELO Gam1, dengue virus envelope protein, human herpesvirus 6 IE2, and human cytomegalovirus IE2 have been shown to interact with proteins in the SUMOylation pathway either by preventing or inducing SUMO conjugation of target proteins (Ahn et al., 2001; Chang et al., 2009; Chiocca, 2007; Tomoiu et al., 2006) , resulting on viral interference with key cellular pathways. As observed with CSFV protein Core, UBC9 also has been shown to interact with the capsid (CA) protein of the Moloney murine leukemia virus (MMLV) (Yueh et al., 2006) . Binding K residues, mapped by alanine-scanning mutagenesis, were within a consensus motif for SUMOylation, and mutations of those residues reduced or abolished MMLV CA SUMOylation. Different from what we have observed, MMLV CA SUMOylation mutants displayed inhibited virus replication, being unable to produce circular viral DNAs or integration into the nucleus. Conversely, CSFV Core mutants were able to establish productive infections both in vitro and in vivo. Therefore, it is possible that CSFV Core protein interactions with the host SUMOylation pathway contributes to curtailing viral clearance, a function that has been removed from Core mutants.
Although the K220A substitution in Core disrupts binding to conjugating enzyme UBC9 in the yeast two-hybrid system, we cannot rule out the possibility that SUMOylation of Core still occurs in the absence of binding to the SUMO-1 conjugating enzyme. That might be reflected by the fact that in swine, mutant CoreΔS220v harboring the K220A substitution that disrupts interaction with UBC9 retained its virulence, albeit animals died later relative to animals inoculated with wild-type virus. Similarly, mutant CoreΔS221v was only partially attenuated in swine. Individual K179A or K180A substitutions in BICv do not affect virus virulence (data not shown); only the double mutant CoreΔS179/180v was partially attenuated in swine. Interestingly, simultaneous mutation of K220A and K221A in CΔS220/221v, losing the binding to both SUMO-1 and UBC9, leads to a strong attenuation of the virulence in swine. It is possible that in vivo, Core-SUMO-1/UBC9 binding requires all four Lys residues (K179. K180, K220, and K221), since complete attenuation of wild-type virus was observed only when all four K-to-A substitutions were introduced into Core protein.
In general, SUMO-targeted proteins exhibit SUMOylation-dependent subcellular localization (Sarge and Park-Sarge, 2009 ). However, substitution of SUMOylation site lysines in ataxin-1 did not affect ataxin-1, a cellular protein, nuclear localization or its ability to form inclusions. Analysis of CSFV Core protein localization in swine cells using GFP-Core fusion proteins showed that substitutions of all putative SUMOylation sites do not affect cellular localization with core appearing in the nucleus, and in small structures within the cell (data not shown).
In summary, we identified the first swine host protein-binding partners for the CSFV Core protein: SUMO-1 and UBC9. Both of these proteins are involved in the SUMOylation pathway, and the putative binding/SUMOylation residues were mapped to two distinct regions in the Core protein. Furthermore, it is shown that disruption of specific residues within these distinct regions of Core protein completely abrogate virus virulence, demonstrating that acquisition of attenuation correlates with loss of binding to components of the SUMOylation pathway, SUMO-1 and UBC9. Although the role of SUMOylation within CSFV Core function is not clear, data indicates that the mechanism may support virus proliferation. It is of paramount importance to gain insights into host-viral protein interactions to understand the mechanisms of viral virulence and immune system evasion. Understanding the pathways and the protein players involved is necessary for developing and understanding better countermeasures to control virus infection in swine.
Materials and methods

Viruses and cells
Swine kidney cells (SK6) (Terpstra et al., 1990) , free of BVDV, were cultured in Dulbecco's minimal essential media (DMEM) (Gibco, Grand Island, NY) with 10% fetal calf serum (FCS) (Atlas Biologicals, Fort Collins, CO). CSFV strain Brescia was propagated in SK6 cells and used for the construction of an infectious cDNA clone (IC) (Risatti et al., 2005a) . Growth kinetics was assessed on primary swine macrophage cell cultures prepared as described (Zsak et al., 1996) . Titration of CSFV from clinical samples was performed using SK6 cells in 96-well plates (Costar, Cambridge, MA). Viral infectivity was detected, after 4 days in culture, by an immunoperoxidase assay using the CSFV monoclonal antibody WH303 (Edwards et al., 1991) and the Vectastain ABC kit (Vector Laboratories, Burlingame, CA). Titers were calculated using the method of Reed and Muench, 1938 and expressed as TCID 50 /ml. As performed, test sensitivity was ≥1.8 TCID 50 /ml.
Construction of CSFV CoreΔS (CΔS) mutants
A full-length IC of the virulent CSFV Brescia strain (pBIC) (Risatti et al., 2005a) was used as a template in which putative SUMO binding sites in the Core protein were mutated. SUMO binding sites were predicted using the SUMOplot Analysis Program (www.abgent.com/ tools/SUMOplot) with the consensus sequence ΨKxD/E/P/G (where Ψ is a bulky hydrophobic residue) within CSFV strain Brescia Core protein [GenBank accession number AY578687, (Risatti et al., 2005a) ] (Figs. 2 and 3) . Lysine (K)-to-alanine (A) amino acid substitutions were introduced by site-directed mutagenesis using the QuickChange XL Site-Directed Mutagenesis kit (Stratagene, Cedar Creek, TX; Table 1 ) performed per manufacturer's instructions and using the following primers (only forward primer sequences are shown): CoreΔS179: 5′-ggtgcaagtgcaagtaaagaggcgaaaccagataggatcaacaa-3′; Cor eΔS180: 5′-gcaagtgcaagtaaagaga aggcaccagataggatcaacaaggg-3′; Cor eΔS220: 5′-ggaaggagtaaaataccaggtcaaagcgaaaggtaaagttaagggaaag aat-3′; CoreΔS221: 5′-aggagtaaaataccaggtcaaaaaggcaggtaaagttaagggaaagaa tacc-3′; CoreΔS246: 5′-aataa accaccagaatctaggaaggcattagaaaaagccc tattggcatg-3′; CoreΔS179/180: 5′-ttgtagtggaaggagtaaaataccaggtc a aagcggcaggtaaagttaagggaaagaatacc-3′ CoreΔS220/221: 5′-gatggtg caagtgcaagtaaagaggcggcaccagataggat caacaagggtaa-3′; and CoreΔS179/ 180/220/221: 5′-ttgtagtggaaggagtaaaataccaggtcaaagcggcaggtaaa gttaagggaaagaatacc-3′ and 5′-gatggtgcaagtgcaagtaaagaggcggcaccaga taggatcaacaagggtaa-3′ . 
In vitro rescue of CSFV Brescia and CΔS mutants
Full-length genomic clones were linearized with SrfI and in vitro transcribed using the T7 MEGAscript system (Ambion, Austin, TX). RNA was precipitated with LiCl and transfected into SK6 cells by electroporation at 500 V, 720 Ω, 100 W with a BTX 630 electroporator (BTX, San Diego, CA). Cells were seeded in 12-well plates and incubated for 4 days at 37°C and 5% CO 2 . Virus was detected by immunoperoxidase staining as described above, and stocks of rescued viruses were stored at −70°C.
DNA sequencing and analysis
Full-length clones and in vitro-rescued viruses were completely sequenced with CSFV-specific primers by the dideoxynucleotide chain-termination method (Sanger et al., 1977) . Viruses recovered from infected animals were sequenced in the mutated region. Sequencing reactions were prepared with the Dye Terminator Cycle Sequencing Kit (Applied Biosystems, Foster City, CA). Reaction products were sequenced on an ABI PRISM 3730xl automated DNA sequencer (Applied Biosystems, Foster City, CA). Sequence data were assembled with the Phrap software program (http://www.phrap. org), with confirmatory assemblies performed using CAP3 (Huang and Madan., 1999) . The final DNA consensus sequence represented an average five-fold redundancy at each base position. Sequence comparisons were conducted using BioEdit software (http://www. mbio.ncsu.edu/BioEdit/bioedit.html).
Development of the cDNA library
A porcine macrophage cDNA expression library was constructed (Clontech, Mountain View, CA) using monocytes/macrophages obtained from healthy noninfected 40-lb swine. Macrophage cultures were prepared from defibrinated swine blood. Cells were cultured in plastic Primaria tissue culture flasks (BD Falcon, Franklin Lakes, NJ) in Roswell Park Memorial Institute-1640 medium (RPMI 1640; Invitrogen, Carlsbad, CA) containing 30% vol./vol. L929 cell supernatant, 20% fetal bovine serum (Invitrogen), and antibiotics-antimycotics (Invitrogen), for 48 hours (37°C in 5% CO 2 ). Adherent cells were detached from the plastic by using 10 mM EDTA in phosphate-buffered saline and then reseeded into Primaria 6-well dishes at a density of 5 × 10 6 cells per well and incubated for an additional 24 hours at 37°C in 5% CO 2 . Cells were detached using 10 mM EDTA in phosphate-buffered saline, spun at 500 × g for 10 minutes, with subsequent total RNA extraction using an RNeasy Mini kit (Qiagen, Valencia, CA). Contaminant genomic DNA was removed by DNase treatment using TURBO DNA-free (Ambion, Austin, TX). After DNase treatment, genomic DNA contamination of RNA stocks was assessed by real-time PCR amplification targeting the porcine β-actin gene. RNA quality was assessed by using RNA Nano chip on an Agilent Bioanalyzer 2100 (Agilent, Santa Clara, CA). Cellular proteins were expressed as GAL4 activation domain (AD) fusion proteins while CSFV proteins were expressed as GAL4-binding domain (BD) fusion proteins.
Library screening
The GAL4-based yeast two-hybrid system provides a transcriptional assay for detection of protein-protein interactions (Chien et al., 1991; Fields and Song, 1989) . The "bait" protein, CSFV strain Brescia Core protein, was expressed with an N-terminus fusion to the GAL4 binding domain (BD). Full-length Core protein (amino acid residues 168-268 of the CSFV polyprotein) was used for screening and for full-length mutant protein construction. The Core fragments used for mapping were made using amino acids 168-212 for the amino half and amino acids 211-268 for the carboxyl half. As "prey," the previously described swine macrophage cDNA library containing proteins were fused to the GAL4 activation domain (AD) was used. Histidine and adenine reporter genes were used for growth selection in addition to two-color selection genes, X-gal (blue + /white − ) and X-α-gal (blue + /white − ). The swine macrophage library used here contains 3 × 10 6 independent cDNA clones. To screen, yeast strain AH109 (Clontech) carrying Core protein was transformed with library plasmid DNA with subsequent selection on plates lacking tryptophan, leucine, histidine, and adenine. Tryptophan and leucine are used for plasmid selection, while histidine and adenine are used for identification of positive interacting library fusions. Once identified, the positive library plasmids were recovered in Escherichia coli and sequenced to identify the cellular interacting protein. Sequence analysis also determined if the library proteins (cellular) were in-frame with the activation domain. To eliminate false positive interactions all library-activation domain fusion proteins were retransformed into strains carrying the viral protein-binding domain fusion proteins, as well as into strains carrying a Lam-binding domain fusion, with vectors that only contain the binding domain as negative controls. Lam is human Lamin C, commonly used as a negative control in the yeast two-hybrid system, as Lamin C does not form complexes or interact with most other proteins; however, some studies have shown Lamin C to interact with UBC9, thus binding domain-only vector was used for this purpose. The SUMO-1 recovered from the library contained amino acids (29-101) of porcine SUMO-1 (NCBI Reference Sequence: NP_001106146.1) amino terminal fused to the GAL4 activation domain. The UBC9 protein recovered was similar to Homo sapiens UBC9 (93% identity) and contained amino acids 2-172 of H. sapiens UBC9 (BAD92225) amino terminal fused to the GAL4 activation domain.
Animal infections
Each of the Core mutants or CoreΔSv was initially screened for its virulence phenotype in swine relative to the virulent strain Brescia. Swine used in all animal studies were 10 to 12 weeks old, 40-lb commercial breed pigs inoculated intranasally with 10 5 TCID 50 of either mutant or wild-type parental virus (BICv). For screening, pigs were randomly allocated into groups of at least two animals each, and pigs in each group were inoculated with one of the CoreΔSv (Table 1) or BICv. Clinical signs (anorexia, depression, purple skin discoloration, staggering gait, diarrhea, and cough) and changes in body temperature were recorded daily throughout the 21-day experiment. Total and differential white blood cell and platelet counts were obtained using a Beckman Coulter ACT (Beckman, Coulter, CA). Blood, serum, nasal swabs and tonsil scrapings were collected at times after challenge. Samples were processed for virus detection as described before (Risatti et al., 2005a) . For protection studies, pigs were inoculated with 10 5 TCID 50 of the corresponding CoreΔSv. At 28 days postinoculation (DPI) animals were intranasally challenged with 10 5 TCID 50 of BICv. Clinical signs and body temperature were recorded daily throughout the experiment as described above. CSFV antibodies were detected in sera using a commercially available ELISA (IDEXX HerdCheck CSFV Antibody Test Kit, Westbrook, ME).
